Laboratory of Pharmaceutics and Nanotechnology, School of Pharmacy, Federal University of Ouro Preto, Minas Gerais, Brazil.
Laboratory of Pharmaceutics and Nanotechnology, School of Pharmacy, Federal University of Ouro Preto, Minas Gerais, Brazil.
Biomed Pharmacother. 2022 Jan;145:112464. doi: 10.1016/j.biopha.2021.112464. Epub 2021 Dec 1.
IR780 is a near-infrared fluorescent dye, which can be applied as a photosensitizer in photodynamic (PDT) and photothermal (PTT) therapies and as a biodistribution tracer in imaging techniques. We investigated the growth and migration inhibition and mechanism of death of breast tumor cells, MCF-7 and MDA-MB-231, exposed to polymeric nanocapsules (NC) comprising IR780 covalently linked to the biodegradable polymer PLA (IR-PLA) and IR780 physically encapsulated (IR780-NC) in vitro. Both types of NC had mean diameters around 120 nm and zeta potentials around -40 mV. IR-PLA-NC was less cytotoxic than IR780 NC to a non-tumorigenic mammary epithelial cell line, MCF-10A, which is an important aspect of selectivity. Free-IR780 was more cytotoxic than IR-PLA-NC for MCF-7 and MDA-MB-231 cells after illumination with a 808 nm laser. IR-PLA NC was effective to inhibit colony formation (50%) and migration (30-40%) for both cancer cell lines. MDA-MB-231 cells were less sensitive to all IR780 formulations compared to MCF-7 cells. Cell uptake was higher with IR-PLA-NC than with IR780-NC and free-IR780 in both cancer cell lines (p < 0.05). NC uptake was higher in MCF-7 than in MDA-MB-231 cells. IR-PLA-NC induced a higher percentage of apoptosis upon illumination in MDA-MB-231 than in MCF-7 cells. The necrosis mechanism of death predominated in treatments with free-IR780 and with encapsulated IR780 NC, suggestive of damages at the plasma membrane. IR780 conjugated with PLA increased the apoptotic pathway and demonstrated potential as a multifunctional theranostic agent for breast cancer treatment with increased cellular uptake, photodynamic activity and more reliable tracking in cell-image studies.
IR780 是一种近红外荧光染料,可作为光动力疗法 (PDT) 和光热疗法 (PTT) 的光敏剂,以及成像技术中的生物分布示踪剂。我们研究了暴露于聚合物纳米胶囊 (NC) 对乳腺癌细胞 MCF-7 和 MDA-MB-231 的生长和迁移抑制以及死亡机制,该 NC 由共价连接到可生物降解聚合物 PLA 的 IR780(IR-PLA)和物理包封的 IR780(IR780-NC)组成。两种类型的 NC 的平均直径约为 120nm,zeta 电位约为-40mV。IR-PLA-NC 对非致瘤性乳腺上皮细胞 MCF-10A 的细胞毒性低于游离 IR780-NC,这是选择性的一个重要方面。在 808nm 激光照射下,游离 IR780 对 MCF-7 和 MDA-MB-231 细胞的细胞毒性高于 IR-PLA-NC。IR-PLA NC 能有效抑制两种癌细胞系的集落形成(50%)和迁移(30-40%)。与 MCF-7 细胞相比,MDA-MB-231 细胞对所有 IR780 制剂的敏感性较低。在两种癌细胞系中,IR-PLA-NC 的细胞摄取量均高于游离 IR780-NC 和游离 IR780(p<0.05)。在 MCF-7 细胞中的摄取量高于 MDA-MB-231 细胞。与 MCF-7 细胞相比,IR-PLA-NC 诱导 MDA-MB-231 细胞在光照下凋亡的比例更高。死亡的坏死机制在游离 IR780 和包封的 IR780-NC 的治疗中占主导地位,提示细胞膜损伤。与 PLA 偶联的 IR780 增加了凋亡途径,为乳腺癌治疗提供了一种多功能治疗药物,具有更高的细胞摄取率、光动力活性和更可靠的细胞成像研究中的示踪。